newsfilter
← Latest News
Business Wire·

AgeX Therapeutics and LyGenesis Terminate Merger Negotiations

AgeX Therapeutics, Inc. (("AgeX", NYSE:AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. ("LyGenesis"), a privately held biotechnology company developing cell therapies that enable organ reg